Halozyme Therapeutics shares owned by Ifrah Financial Services
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Ifrah Financial Services
from 13F filings
Historical chart of Ifrah Financial Services investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Ifrah Financial Services consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Ifrah Financial Services
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-03-31 | $454k | 7.0k | 64.63 |
| 2023-12-31 | $224k | 6.1k | 36.96 |
| 2023-09-30 | $246k | 6.4k | 38.20 |
| 2023-06-30 | $234k | 6.5k | 36.07 |
| 2023-03-31 | $252k | 6.6k | 38.19 |
| 2022-12-31 | $384k | 6.8k | 56.90 |
| 2022-09-30 | $278k | 7.0k | 39.59 |
| 2022-06-30 | $310k | 7.0k | 43.98 |